AI assistant
Sending…
LABCORP HOLDINGS INC. — Director's Dealing 2015
Aug 4, 2015
30237_dirs_2015-08-04_59c0cfb5-7b3c-4a70-abf9-36ce37cff738.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2015-07-31
Reporting Person: HERRING JOSEPH L (CEO of Covance Drug Division)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-07-31 | Common Stock | M | 19990 | — | Acquired | 19990 | Direct |
| 2015-07-31 | Common Stock | F | 9586 | $127.29 | Disposed | 10404 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-07-31 | Restricted Stock Unit | $ | M | 19990 | Disposed | Common Stock (19990) | Direct |
Footnotes
F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2: Stock withholding to satisfy tax withholding obligations.
F3: On February 23, 2015, the reporting person was granted 19,990 Restricted Stock Units, which vested in full on July 31, 2015.
More from LABCORP HOLDINGS INC.
Regulatory Filings
2026
May 27
Declaration of Voting Results & Voting Rights Announcements
2026
May 26
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
May 4
Earnings Release
2026
Apr 30
Annual Report
2026
Apr 10
Proxy Solicitation & Information Statement
2026
Apr 10
Notice of Dividend Amount
2026
Apr 9
Regulatory Filings
2026
Mar 31
Director's Dealing
2026
Mar 30